D L Barlow

794 total citations
11 papers, 634 citations indexed

About

D L Barlow is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, D L Barlow has authored 11 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in D L Barlow's work include Immunotherapy and Immune Responses (7 papers), Hepatitis B Virus Studies (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). D L Barlow is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Hepatitis B Virus Studies (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). D L Barlow collaborates with scholars based in United States. D L Barlow's co-authors include Albert F. LoBuglio, Susan E. Moore, David T. Curiel, Robert M. Conry, Karen O. Allen, Frosty Loechel, L A Sumerel, R M Conry, Denise R. Shaw and Jeffrey Schlom and has published in prestigious journals such as Vaccine, The Journal of Gene Medicine and Immunopharmacology.

In The Last Decade

D L Barlow

11 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D L Barlow United States	10	448	341	182	181	79	11	634
R M Conry United States	11	357 0.8×	476 1.4×	226 1.2×	129 0.7×	72 0.9×	11	722
Nadine Bizouarne France	12	567 1.3×	407 1.2×	229 1.3×	338 1.9×	68 0.9×	17	834
Karen O. Allen United States	10	334 0.7×	201 0.6×	123 0.7×	194 1.1×	57 0.7×	10	456
Sungae Cho South Korea	8	582 1.3×	260 0.8×	194 1.1×	151 0.8×	28 0.4×	11	897
M Berger Austria	9	267 0.6×	220 0.6×	179 1.0×	169 0.9×	48 0.6×	13	480
Karen M. Hauda United States	10	536 1.2×	298 0.9×	251 1.4×	432 2.4×	74 0.9×	11	899
J M Ruehlmann United States	7	281 0.6×	162 0.5×	85 0.5×	119 0.7×	119 1.5×	8	427
Valérie Lacabanne France	6	788 1.8×	277 0.8×	69 0.4×	142 0.8×	40 0.5×	6	922
Mili Gu United States	10	226 0.5×	294 0.9×	135 0.7×	73 0.4×	38 0.5×	16	595
Matthias Schroff Germany	16	316 0.7×	306 0.9×	190 1.0×	125 0.7×	33 0.4×	39	685

Countries citing papers authored by D L Barlow

Since Specialization

Citations

This map shows the geographic impact of D L Barlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D L Barlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D L Barlow more than expected).

Fields of papers citing papers by D L Barlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D L Barlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D L Barlow. The network helps show where D L Barlow may publish in the future.

Co-authorship network of co-authors of D L Barlow

This figure shows the co-authorship network connecting the top 25 collaborators of D L Barlow. A scholar is included among the top collaborators of D L Barlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D L Barlow. D L Barlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Neidhart, Jeffrey D., Karen O. Allen, D L Barlow, et al.. (2003). Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor. Vaccine. 22(5-6). 773–780. 50 indexed citations

Conry, Robert M., David T. Curiel, Theresa V. Strong, et al.. (2002). Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.. PubMed. 8(9). 2782–7. 109 indexed citations

White, Stephen, Albert F. LoBuglio, Ramin B. Arani, et al.. (2000). Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine. The Journal of Gene Medicine. 2(2). 135–140. 19 indexed citations

Conry, R M, M B Khazaeli, Mansoor N. Saleh, et al.. (1999). Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.. PubMed. 5(9). 2330–7. 71 indexed citations

Conry, Robert M., Shanta Bantia, D L Barlow, et al.. (1998). Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells. Immunopharmacology. 40(1). 1–9. 15 indexed citations

Conry, R M, Stephen White, Patricia N. Fultz, et al.. (1998). Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.. PubMed. 4(11). 2903–12. 28 indexed citations

Conry, Robert M., Georg Widera, Albert F. LoBuglio, et al.. (1996). Selected strategies to augment polynucleotide immunization.. PubMed. 3(1). 67–74. 97 indexed citations

Conry, Robert M., Albert F. LoBuglio, Frosty Loechel, et al.. (1995). A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.. PubMed. 2(1). 59–65. 95 indexed citations

Conry, R M, Albert F. LoBuglio, Frosty Loechel, et al.. (1995). A carcinoembryonic antigen polynucleotide vaccine for human clinical use.. PubMed. 2(1). 33–8. 52 indexed citations

10.

Conry, R M, Albert F. LoBuglio, Judy Kantor, et al.. (1994). Immune response to a carcinoembryonic antigen polynucleotide vaccine.. PubMed. 54(5). 1164–8. 96 indexed citations

11.

Barlow, D L. (1953). Pulmonary Tuberculosis in Ceylon. BMJ. 1(4810). 612–613. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact